Detalhe da pesquisa
1.
36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease.
Alzheimers Dement
; 17(1): 29-40, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920957
2.
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials.
J Neurol Neurosurg Psychiatry
; 87(9): 993-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27010616
3.
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
Alzheimers Dement
; 10(6): 666-74, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24751827
4.
Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review.
Alzheimers Res Ther
; 15(1): 98, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226162
5.
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings.
Neurol Clin Pract
; 13(2): e200127, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891463
6.
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study.
EBioMedicine
; 94: 104665, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392597
7.
Perspectives on statistical strategies for the regulatory biomarker qualification process.
Biomark Med
; 15(9): 669-684, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34037457
8.
GenoRisk: A polygenic risk score for Alzheimer's disease.
Alzheimers Dement (N Y)
; 7(1): e12211, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621978
9.
Value-Generating Exploratory Trials in Neurodegenerative Dementias.
Neurology
; 96(20): 944-954, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674360
10.
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
Alzheimers Res Ther
; 12(1): 66, 2020 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32460855
11.
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Lancet Neurol
; 7(6): 483-93, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18450517
12.
Witness and nonwitness children's violent and peaceful behavior in different types of simulated conflict with peers.
Am J Orthopsychiatry
; 77(2): 206-15, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17535118
13.
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.
Lancet Neurol
; 16(12): 965-975, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29097166
14.
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
J Alzheimers Dis
; 57(2): 447-459, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28269787
15.
Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis.
Alzheimers Res Ther
; 7(1): 28, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25991927
16.
Gender, types of conflict, and individual differences in the use of violent and peaceful strategies among children who have and have not witnessed interparental violence.
Am J Orthopsychiatry
; 73(2): 141-53, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12769236
17.
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
J Clin Psychiatry
; 75(6): 652-60, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816373
18.
Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease.
Alzheimers Res Ther
; 5(3): 22, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23680123
19.
Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time.
Alzheimers Res Ther
; 4(4): 24, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22805433
20.
Requiring an amyloid-ß1-42 biomarker may improve the efficiency of a study, and simulations may help in planning studies.
Alzheimers Res Ther
; 3(2): 10, 2011 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21457497